AI precision pipeline

Drug and diagnostic pipeline

Our precision pipeline will deliver the right treatment to the right patient
Drug R&D
Indication
Solid tumors
Mesothelioma
Bladder cancer
DLBCL
Ovarian cancer
Early discovery
Pre-clinical
Phase I
Phase II
OKN4395
AI Diagnostics
Indication
Breast cancer
Lung cancer
Endometrial cancer
Gastric cancer
Biliary cancer
Breast cancer
Pan-cancer
Proof of Concept
Development
Regulatory approval
Approved
MSIntuit® CRC
RlapsRisk® BC
TLS Detect Pan-Tumor
BRCAura BC - in collaboration with AZ
MSIntuit® EC - in collaboration with MSD
MSIntuit® GC - in collaboration with MSD
MSIntuit® BTC - in collaboration with MSD
HER2-low IHC scoring
IHC biomarker
Key
Biomarker screening tool
Outcome prediction tool
Pathologist support tool

What makes our pipeline different?

Powered by multimodal patient data, our AI models match novel targets with patient subgroups to identify the best treatments.

We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation.